Fig. 2.

TCC deletion in IFNAR1 is associated with decreased risk of developing severe pulmonary pathology. a The HRCT scores of pulmonary TB patients carrying rs72552343 TCC/TCC (n = 421) or TCC/Del (n = 32) genotypes before the initiation of anti-TB chemotherapy. Circles denote individual patients and bars represent group means. b Paired analysis of HRCT scores before and 2 years after completion of anti-TB chemotherapy in pulmonary TB patients carrying rs72552343 TCC/TCC (n = 43) or TCC/Del (n = 10). Each paired data set represents an individual patient. Statistical analyses were performed using Student’s t-test. *p < 0.05 and **p < 0.01